Hair cloning, a therapy with stem cells for androgenic alopecia, is emerging as one of the great challenges in the treatment of common baldness and it is estimated that it can be effective within about ten years, according to experts in alopecia. This has been highlighted in the Trichology Course that was held this Wednesday at the Ramón y Cajal Hospital, Madrid, led by Dr. Sergio Vañó, dermatologist and coordinator of the Trichology Unit, and Dr. Pedro Jaén, chief of service of Dermatology of the same hospital.
The course, which has the assistance of more than 200 specialists, reviews the latest therapeutic advances and diagnostics in trichology, the part of dermatology that deals with the problems of hair loss. Dr. Vañó stressed that “capillary cloning is the great therapeutic novelty in patients with androgenic alopecia, the most frequent form of baldness that affects 70% of men and 30% of women.”
While this type of stem cell therapy has given positive results in mice, “the results in human studies show very low rates of effectiveness, although it is expected to be a reality in a minimum of ten years,” he said. Dr. Vañó pointed out that the trichoscopy, which uses a microscope to see the hair up close, is another diagnostic novelty since “it allows an evaluation of the type of alopecia in a much more specific way”.
Beyond the improvement of therapies with stem cells, this doctor has ensured that another of the challenges of the science that studies hair involves raising awareness among the population that hair transplants must be done in centers that have adequate resources and personnel. , as well as finding curative treatments for alopecia areata, “a challenge for which we will still have to wait for something more”, has qualified.
Another of the messages that have centered this course is the vindication of the work of the specialty in the own health of the patient. According to Vañó, “alopecia is not a banal or merely aesthetic issue because it can negatively influence the quality of life of the patient.” One of the most representative cases is that of alopecia due to chemotherapy, which is why “10% of women who are going to undergo a chemotherapy treatment for breast cancer do not consider doing it for fear of losing their hair”, Vañó has pointed out.
Leer más: https://www.antena3.com/noticias/salud/sera-solucion-definitiva-alopecia-clonacion-capilar-sera-efectiva-diez-anos_201803145aa982d40cf2495a410075ca.html